DUBLIN--(Alkermes plc (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the Citi 2013 Global Healthcare Conference on Monday, Feb. 25, 2013, at 11:05 a.m. EST (4:05 p.m. GMT) from the Hilton New York Hotel in New York City. In addition, Alkermes’ corporate presentation will be webcast live at the 2013 RBC Capital Markets’ Healthcare Conference on Tuesday, Feb. 26, 2013, at 8:00 a.m. EST (1:00 p.m. GMT) from The New York Palace Hotel in New York City. The Alkermes corporate presentation will also be webcast live at Cowen and Company’s 33rd Annual Health Care Conference on Monday, March 4, 2013, at 3:30 p.m. EST (8:30 p.m. GMT) from The Boston Marriott Copley Place in Boston. These presentations may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.)--
Alkermes plc is a fully integrated, global biopharmaceutical company that applies its scientific expertise and proprietary technologies to develop innovative medicines that improve patient outcomes. The company has a diversified portfolio of more than 20 commercial drug products and a substantial clinical pipeline of product candidates that address central nervous system (CNS) disorders such as addiction, schizophrenia and depression. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and manufacturing facilities in Gainesville, Georgia and Wilmington, Ohio. For more information, please visit Alkermes’ website at www.alkermes.com.